Precipio, Inc. (PRPO)
NASDAQ: PRPO · Real-Time Price · USD
6.26
+0.29 (4.87%)
At close: Mar 28, 2025, 4:00 PM
5.97
-0.29 (-4.64%)
After-hours: Mar 28, 2025, 4:05 PM EDT

Company Description

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States.

It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.

It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Precipio, Inc.
Precipio logo
Country United States
Industry Diagnostics & Research
Sector Healthcare
Employees 57
CEO Ilan Danieli

Contact Details

Address:
4 Science Park, 3rd Floor
New Haven, Connecticut 06511
United States
Phone 203 787 7888
Website precipiodx.com

Stock Details

Ticker Symbol PRPO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001043961
CUSIP Number 74019L503
ISIN Number US74019L6020
Employer ID 91-1789357
SIC Code 3826

Key Executives

Name Position
Ilan Danieli Founder, President, Chief Executive Officer and Director
Matthew Gage Chief Financial Officer
Miri Chiko-Radomski Chief Legal Counsel and People Officer

Latest SEC Filings

Date Type Title
Mar 27, 2025 10-K Annual Report
Mar 17, 2025 8-K Current Report
Jan 21, 2025 8-K Current Report
Jan 16, 2025 8-K Current Report
Jan 16, 2025 S-8 Securities to be offered to employees in employee benefit plans
Dec 11, 2024 144 Filing
Nov 12, 2024 144 Filing
Nov 7, 2024 8-K Current Report
Nov 6, 2024 10-Q Quarterly Report
Sep 6, 2024 8-K Current Report